Tapewire

NYSE · USD

PRLB

Proto Labs Inc

Export transactions ↓
Tapewire entity
4553
SEC CIK
0001443669
Parsed reports
257

Last 12 months

Inside the activity.

0 purchase rows · 15 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202606
Jun 202602
Jul 202600
Aug 202600
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 10, 2026 Filed Feb 12, 2026 21:50 UTC
Kenison Michael R.Chief Operations Officer
Tax withholdingCommon Stock 2,684 $53.18 $142,735.12
Disclosure

SEC source: 0001870293-26-000004 · form4-02122026_090223.xml · nonDerivative · entry 1

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,842

Read SEC document
February 10, 2026 Filed Feb 12, 2026 21:48 UTC
Schumacher DanielChief Financial Officer
Tax withholdingCommon Stock 6,809 $53.18 $362,102.62
Disclosure

SEC source: 0001894753-26-000003 · form4-02122026_090244.xml · nonDerivative · entry 1

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,836

Read SEC document
February 06, 2026 Filed Feb 9, 2026 21:53 UTC
Kenison Michael R.Chief Operations Officer
SaleCommon Stock 2,500 $60.00 $150,000.00
Disclosure

SEC source: 0001628280-26-006501 · wk-form4_1770674010.xml · nonDerivative · entry 1

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,526

F1 · kind: This transaction was executed pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person on August 15, 2025.

Read SEC document
January 29, 2026 Filed Feb 4, 2026 23:16 UTC
Kenison Michael R.Chief Operations Officer
GrantCommon Stock 8,128 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-005553 · wk-form4_1770246977.xml · nonDerivative · entry 1

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,026

Read SEC document
January 29, 2026 Filed Feb 4, 2026 23:15 UTC
Schumacher DanielChief Financial Officer
GrantCommon Stock 20,686 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-005552 · wk-form4_1770246948.xml · nonDerivative · entry 1

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,645

Read SEC document
November 25, 2025 Filed Nov 26, 2025 22:37 UTC
Kenison Michael R.Chief Operations Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 3,048 $0.00 Strike: $33.84 $0.00
Disclosure

SEC source: 0001870293-25-000004 · wk-form4_1764196640.xml · derivative · entry 3

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,664

Underlying: Common Stock · 3,048 shares

Expires 2033-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2024, and on each February 13th thereafter until all shares subject to the award are fully vested.

Read SEC document
November 25, 2025 Filed Nov 26, 2025 22:37 UTC
Kenison Michael R.Chief Operations Officer
SaleCommon Stock 3,048 $50.17 $152,930.66
Disclosure

SEC source: 0001870293-25-000004 · wk-form4_1764196640.xml · nonDerivative · entry 2

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,898

F2 · shares: These shares were acquired and sold pursuant to Reporting Person's 10b5-1 plan adopted August 15, 2025.

F3 · price: Reflects the weighted average price of 3,048 shares of Common Stock of the issuer sold by the Reporting Person in multiple transactions on November 25, 2025 with sale prices ranging from $50.00 to $50.53 per share. The Reporting Person undertakes to provide upon request by U.S. Securities and Exchange Commission staff, the issuer, or a securityholder of the issuer full information regarding the number of shares sold at each separate price.

Read SEC document
November 25, 2025 Filed Nov 26, 2025 22:37 UTC
Kenison Michael R.Chief Operations Officer
Exercise / conversionCommon Stock 3,048 $33.84 $103,144.32
Disclosure

SEC source: 0001870293-25-000004 · wk-form4_1764196640.xml · nonDerivative · entry 1

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,946

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 57 shares of Common Stock of the issuer purchased on November 15, 2025 through the issuer's Employee Stock Purchase Plan program.

Read SEC document
November 25, 2025 Filed Dec 3, 2025 23:13 UTC Amendment
Kenison Michael R.Chief Operations Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 3,048 $0.00 Strike: $33.84 $0.00
Disclosure

SEC source: 0001870293-25-000007 · wk-form4a_1764803630.xml · derivative · entry 3

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,048 shares

Expires 2026-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Fully vested.

F5 · derivative.expiration_date: This amendment reflects an adjustment to the expiration date of the Employee Stock Options to correct a clerical error in the reporting person's Form 4 filed on November 25, 2025. All transaction details were accurately reported on the original Form 4.

Read SEC document
November 25, 2025 Filed Dec 3, 2025 23:13 UTC Amendment
Kenison Michael R.Chief Operations Officer
SaleCommon Stock 3,048 $50.17 $152,930.66
Disclosure

SEC source: 0001870293-25-000007 · wk-form4a_1764803630.xml · nonDerivative · entry 2

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,898

F2 · shares: These shares were acquired and sold pursuant to Reporting Person's 10b5-1 plan adopted August 15, 2025.

F3 · price: Reflects the weighted average price of 3,048 shares of Common Stock of the issuer sold by the Reporting Person in multiple transactions on November 25, 2025 with sale prices ranging from $50.00 to $50.53 per share. The Reporting Person undertakes to provide upon request by U.S. Securities and Exchange Commission staff, the issuer, or a securityholder of the issuer full information regarding the number of shares sold at each separate price.

Read SEC document
November 25, 2025 Filed Dec 3, 2025 23:13 UTC Amendment
Kenison Michael R.Chief Operations Officer
Exercise / conversionCommon Stock 3,048 $33.84 $103,144.32
Disclosure

SEC source: 0001870293-25-000007 · wk-form4a_1764803630.xml · nonDerivative · entry 1

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,946

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 57 shares of Common Stock of the issuer purchased on November 15, 2025 through the issuer's Employee Stock Purchase Plan program.

Read SEC document
November 17, 2025 Filed Nov 19, 2025 21:13 UTC
Kermisch MarcChief Technology & AI Officer
GrantEmployee Stock Option (right to buy) · Derivative 6,818 $0.00 Strike: $47.07 $0.00
Disclosure

SEC source: 0001443669-25-000014 · wk-form4_1763586795.xml · derivative · entry 2

Kermisch Marc · CIK 0001975999 · Chief Technology & AI Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,818

Underlying: Common Stock · 6,818 shares

Expires 2035-11-17

F2 · derivative.exercise_date: Stock option vests annually over four years commencing on November 15, 2026.

Read SEC document
November 17, 2025 Filed Nov 19, 2025 21:13 UTC
Kermisch MarcChief Technology & AI Officer
GrantCommon Stock 3,718 $0.00 $0.00
Disclosure

SEC source: 0001443669-25-000014 · wk-form4_1763586795.xml · nonDerivative · entry 1

Kermisch Marc · CIK 0001975999 · Chief Technology & AI Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,718

F1 · shares: Restricted stock units that vest annually over four years commencing on November 15, 2026.

Read SEC document
August 05, 2025 Filed Aug 7, 2025 20:09 UTC PurchaseCommon Stock 1,715 $43.79 $75,104.65
Disclosure

SEC source: 0001628280-25-038875 · wk-form4_1754597337.xml · nonDerivative · entry 1

Gawlick Rainer · CIK 0001542473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,883

F1 · price: Reflects the weighted average price of 1,715 shares of common stock of Proto Labs Inc. purchased by the reporting person in multiple transactions on August 5, 2025 with purchase prices ranging from $43.45 to $43.925 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
August 04, 2025 Filed Aug 7, 2025 00:48 UTC
Krishna SureshDirector · President and CEO
PurchaseCommon Stock 1,725 $43.51 $75,054.75
Disclosure

SEC source: 0001628280-25-038522 · wk-form4_1754527689.xml · nonDerivative · entry 1

Krishna Suresh · CIK 0001488151 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,021

F1 · price: Reflects the weighted average price of 1,725 shares of common stock of Proto Labs Inc. purchased by the reporting person in multiple transactions on August 4, 2025 with purchase prices ranging from $43.47 to $43.53 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
May 23, 2025 Filed May 28, 2025 17:52 UTC GrantCommon Stock 3,939 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-028222 · wk-form4_1748469155.xml · nonDerivative · entry 1

Greiner Stacy · CIK 0001894943 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,644

F1 · shares: Deferred stock units that vest in full on the first anniversary of the grant date or the date but must be retained by the reporting person until the completion of the reporting person's service on the Company's Board of Directors.

Read SEC document
May 23, 2025 Filed May 28, 2025 22:04 UTC GrantCommon Stock 3,939 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-028229 · wk-form4_1748469882.xml · nonDerivative · entry 1

Black Archie C. · CIK 0001489095 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,218

F1 · shares: Deferred stock units that vest in full on the first anniversary of the grant date or the date but must be retained by the reporting person until the completion of the reporting person's service on the Company's Board of Directors.

F2 · balance_after: Reporting Person's beneficial ownership amount has been increased by 1,565 shares of common stock as a result of a reconciliation of his direct holdings against the amount set forth in his prior Form 4 filed on May 24, 2024.

Read SEC document
May 23, 2025 Filed May 28, 2025 20:59 UTC
Krishna SureshDirector · President and CEO
GrantEmployee Stock Option (right to buy) · Derivative 29,522 $0.00 Strike: $36.82 $0.00
Disclosure

SEC source: 0001628280-25-028191 · wk-form4_1748465937.xml · derivative · entry 2

Krishna Suresh · CIK 0001488151 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,522

Underlying: Common Stock · 29,522 shares

Expires 2035-05-23

F2 · derivative.exercise_date: 25% of shares subject to the award will vest on May 23, 2026, and on each May 23rd thereafter until all shares subject to the award are fully vested.

Read SEC document
May 23, 2025 Filed May 28, 2025 20:59 UTC
Krishna SureshDirector · President and CEO
GrantCommon Stock 16,296 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-028191 · wk-form4_1748465937.xml · nonDerivative · entry 1

Krishna Suresh · CIK 0001488151 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,296

F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on May 23, 2026, and on each May 23rd thereafter until all shares subject to the award are fully vested.

Read SEC document
May 23, 2025 Filed May 28, 2025 21:54 UTC GrantCommon Stock 3,939 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-028226 · wk-form4_1748469266.xml · nonDerivative · entry 1

Gawlick Rainer · CIK 0001542473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,168

F1 · shares: Deferred stock units that vest in full on the first anniversary of the grant date or the date but must be retained by the reporting person until the completion of the reporting person's service on the Company's Board of Directors.

Read SEC document
May 23, 2025 Filed May 28, 2025 21:54 UTC
Chin MoonhieDirector
GrantCommon Stock 3,939 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-028225 · wk-form4_1748469236.xml · nonDerivative · entry 1

Chin Moonhie · CIK 0001395001 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,096

F1 · shares: Deferred stock units that vest in full on the first anniversary of the grant date or the date but must be retained by the reporting person until the completion of the reporting person's service on the Company's Board of Directors.

Read SEC document
May 23, 2025 Filed May 28, 2025 21:53 UTC
Chand SujeetDirector
GrantCommon Stock 3,939 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-028224 · wk-form4_1748469204.xml · nonDerivative · entry 1

Chand Sujeet · CIK 0001388884 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,653

F1 · shares: Deferred stock units that vest in full on the first anniversary of the grant date or the date but must be retained by the reporting person until the completion of the reporting person's service on the Company's Board of Directors.

Read SEC document
May 23, 2025 Filed May 28, 2025 21:51 UTC GrantCommon Stock 3,939 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-028218 · wk-form4_1748469081.xml · nonDerivative · entry 1

WEHRWEIN SVEN · CIK 0001205069 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,295

F1 · shares: Deferred stock units that vest in full on the first anniversary of the grant date or the date but must be retained by the reporting person until the completion of the reporting person's service on the Company's Board of Directors.

Read SEC document
May 23, 2025 Filed May 28, 2025 21:49 UTC GrantCommon Stock 3,939 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-028217 · wk-form4_1748468973.xml · nonDerivative · entry 1

KRANTZ DONALD G · CIK 0001183159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,653

F1 · shares: Restricted stock units that vest in full on the first anniversary of the grant date.

Read SEC document
May 20, 2025 Filed May 22, 2025 20:39 UTC
Kenison Michael R.Chief Operations Officer
Tax withholdingCommon Stock 204 $40.87 $8,337.48
Disclosure

SEC source: 0001628280-25-027300 · wk-form4_1747946362.xml · nonDerivative · entry 1

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,841

F1 · balance_after: Includes 63 shares of Common Stock of the issuer purchased on May 15, 2025 through the issuer's Employee Stock Purchase Plan program.

Read SEC document
May 20, 2025 Filed May 22, 2025 20:40 UTC
Schumacher DanielChief Financial Officer
Tax withholdingCommon Stock 305 $40.87 $12,465.35
Disclosure

SEC source: 0001628280-25-027303 · wk-form4_1747946405.xml · nonDerivative · entry 1

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,959

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:33 UTC
Kenison Michael R.Chief Operations Officer
GrantEmployee Stock Option (right to buy) · Derivative 6,231 $0.00 Strike: $39.61 $0.00
Disclosure

SEC source: 0001628280-25-008704 · wk-form4_1740691994.xml · derivative · entry 2

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,231

Underlying: Common Stock · 6,231 shares

Expires 2035-02-25

F2 · derivative.exercise_date: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:33 UTC
Kenison Michael R.Chief Operations Officer
GrantCommon Stock 6,943 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-008704 · wk-form4_1740691994.xml · nonDerivative · entry 1

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,982

F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:34 UTC
Schumacher DanielChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 7,931 $0.00 Strike: $39.61 $0.00
Disclosure

SEC source: 0001628280-25-008706 · wk-form4_1740692046.xml · derivative · entry 2

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,931

Underlying: Common Stock · 7,931 shares

Expires 2035-02-25

F2 · derivative.exercise_date: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:34 UTC
Schumacher DanielChief Financial Officer
GrantCommon Stock 4,419 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-008706 · wk-form4_1740692046.xml · nonDerivative · entry 1

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,264

F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:32 UTC
Ryaboy OlegChief Technology Officer
GrantEmployee Stock Option (right to buy) · Derivative 6,798 $0.00 Strike: $39.61 $0.00
Disclosure

SEC source: 0001628280-25-008701 · wk-form4_1740691953.xml · derivative · entry 2

Ryaboy Oleg · CIK 0001945827 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,798

Underlying: Common Stock · 6,798 shares

Expires 2035-02-25

F2 · derivative.exercise_date: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:32 UTC
Ryaboy OlegChief Technology Officer
GrantCommon Stock 7,574 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-008701 · wk-form4_1740691953.xml · nonDerivative · entry 1

Ryaboy Oleg · CIK 0001945827 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,305

F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:31 UTC
Bodor RobertPresident and CEO
GrantEmployee Stock Option (right to buy) · Derivative 33,986 $0.00 Strike: $39.61 $0.00
Disclosure

SEC source: 0001628280-25-008699 · wk-form4_1740691885.xml · derivative · entry 2

Bodor Robert · CIK 0001581088 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,986

Underlying: Common Stock · 33,986 shares

Expires 2035-02-25

F2 · derivative.exercise_date: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:31 UTC
Bodor RobertPresident and CEO
GrantCommon Stock 18,935 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-008699 · wk-form4_1740691885.xml · nonDerivative · entry 1

Bodor Robert · CIK 0001581088 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,579

F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 22:42 UTC
Kenison Michael R.Chief Operations Officer
Tax withholdingCommon Stock 1,696 $45.03 $76,370.88
Disclosure

SEC source: 0001628280-25-006145 · wk-form4_1739918569.xml · nonDerivative · entry 3

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,039

Read SEC document
February 13, 2025 Filed Feb 18, 2025 22:42 UTC
Kenison Michael R.Chief Operations Officer
Tax withholdingCommon Stock 580 $45.03 $26,117.40
Disclosure

SEC source: 0001628280-25-006145 · wk-form4_1739918569.xml · nonDerivative · entry 2

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,735

Read SEC document
February 13, 2025 Filed Feb 18, 2025 22:42 UTC
Kenison Michael R.Chief Operations Officer
GrantCommon Stock 1,894 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006145 · wk-form4_1739918569.xml · nonDerivative · entry 1

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,315

F1 · balance_after: Includes 70 shares of Common Stock of the issuer purchased on November 15, 2024 through the issuer's Employee Stock Purchase Plan program.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 22:42 UTC
Schumacher DanielChief Financial Officer
Tax withholdingCommon Stock 1,264 $45.03 $56,917.92
Disclosure

SEC source: 0001628280-25-006144 · wk-form4_1739918519.xml · nonDerivative · entry 3

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,845

Read SEC document
February 13, 2025 Filed Feb 18, 2025 22:42 UTC
Schumacher DanielChief Financial Officer
Tax withholdingCommon Stock 1,098 $45.03 $49,442.94
Disclosure

SEC source: 0001628280-25-006144 · wk-form4_1739918519.xml · nonDerivative · entry 2

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,109

Read SEC document
February 13, 2025 Filed Feb 18, 2025 22:42 UTC
Schumacher DanielChief Financial Officer
GrantCommon Stock 3,077 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006144 · wk-form4_1739918519.xml · nonDerivative · entry 1

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,207

Read SEC document
February 13, 2025 Filed Feb 18, 2025 22:43 UTC
Bodor RobertPresident and CEO
Tax withholdingCommon Stock 7,268 $45.03 $327,278.04
Disclosure

SEC source: 0001628280-25-006147 · wk-form4_1739918617.xml · nonDerivative · entry 3

Bodor Robert · CIK 0001581088 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,644

Read SEC document
February 13, 2025 Filed Feb 18, 2025 22:43 UTC
Bodor RobertPresident and CEO
Tax withholdingCommon Stock 7,536 $45.03 $339,346.08
Disclosure

SEC source: 0001628280-25-006147 · wk-form4_1739918617.xml · nonDerivative · entry 2

Bodor Robert · CIK 0001581088 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,912

Read SEC document
February 13, 2025 Filed Feb 18, 2025 22:43 UTC
Bodor RobertPresident and CEO
GrantCommon Stock 23,570 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-006147 · wk-form4_1739918617.xml · nonDerivative · entry 1

Bodor Robert · CIK 0001581088 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,448

Read SEC document
February 13, 2025 Filed Feb 18, 2025 22:41 UTC
Ryaboy OlegChief Technology Officer
Tax withholdingCommon Stock 2,461 $45.03 $110,818.83
Disclosure

SEC source: 0001628280-25-006142 · wk-form4_1739918482.xml · nonDerivative · entry 1

Ryaboy Oleg · CIK 0001945827 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,731

F1 · balance_after: Includes 695 shares of Common Stock of the issuer purchased on May 15, 2024 through the issuer's Employee Stock Purchase Plan program.

Read SEC document
September 06, 2024 Filed Sep 9, 2024 20:47 UTC
Bodor RobertPresident and CEO
PurchaseCommon Stock 3,480 $28.68 $99,800.48
Disclosure

SEC source: 0001628280-24-039901 · wk-form4_1725914871.xml · nonDerivative · entry 1

Bodor Robert · CIK 0001581088 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,878

F1 · price: Reflects the weighted average price of 3,480 shares of common stock of Proto Labs Inc. purchased by the reporting person in multiple transactions on September 6, 2024, with purchase prices ranging from $28.49 to $29.07 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

F2 · balance_after: Includes 695 shares of Common Stock of the issuer purchased on May 15, 2024 through the issuer's Employee Stock Purchase Plan program.

Read SEC document
May 23, 2024 Filed May 24, 2024 16:24 UTC GrantCommon Stock 4,701 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-018336 · rdgdoc.xml · nonDerivative · entry 1

Greiner Stacy · CIK 0001894943 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,705

F1 · shares: Deferred stock units ("DSUs") that vest in full on the date of the 2025 Annual Meeting of Shareholders, provided that the date of the 2025 Annual Meeting of Shareholders is at least 50 weeks after the date of the grant. DSUs must be retained by the reporting person until the completion of the reporting person's service on the Company's Board of Directors.

Read SEC document
May 23, 2024 Filed May 24, 2024 20:27 UTC GrantCommon Stock 4,701 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-018342 · rdgdoc.xml · nonDerivative · entry 1

Black Archie C. · CIK 0001489095 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,714

F1 · shares: Deferred stock units ("DSUs") that vest in full on the date of the 2025 Annual Meeting of Shareholders, provided that the date of the 2025 Annual Meeting of Shareholders is at least 50 weeks after the date of the grant. DSUs must be retained by the reporting person until the completion of the reporting person's service on the Company's Board of Directors.

Read SEC document
May 23, 2024 Filed May 24, 2024 20:26 UTC
Chand SujeetDirector
GrantCommon Stock 4,701 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-018340 · rdgdoc.xml · nonDerivative · entry 1

Chand Sujeet · CIK 0001388884 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,714

F1 · shares: Deferred stock units ("DSUs") that vest in full on the date of the 2025 Annual Meeting of Shareholders, provided that the date of the 2025 Annual Meeting of Shareholders is at least 50 weeks after the date of the grant. DSUs must be retained by the reporting person until the completion of the reporting person's service on the Company's Board of Directors.

Read SEC document
May 23, 2024 Filed May 24, 2024 20:25 UTC
Chin MoonhieDirector
GrantCommon Stock 4,701 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-018339 · rdgdoc.xml · nonDerivative · entry 1

Chin Moonhie · CIK 0001395001 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,157

F1 · shares: Deferred stock units ("DSUs") that vest in full on the date of the 2025 Annual Meeting of Shareholders, provided that the date of the 2025 Annual Meeting of Shareholders is at least 50 weeks after the date of the grant. DSUs must be retained by the reporting person until the completion of the reporting person's service on the Company's Board of Directors.

Read SEC document
May 23, 2024 Filed May 24, 2024 20:24 UTC GrantCommon Stock 4,701 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-018337 · rdgdoc.xml · nonDerivative · entry 1

Gawlick Rainer · CIK 0001542473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,229

F1 · shares: Deferred stock units ("DSUs") that vest in full on the date of the 2025 Annual Meeting of Shareholders, provided that the date of the 2025 Annual Meeting of Shareholders is at least 50 weeks after the date of the grant. DSUs must be retained by the reporting person until the completion of the reporting person's service on the Company's Board of Directors.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.